Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes

Neuroscience Letters

Volumn 223, Issue 2, 1997, Pages 133-136

  Avenet, Patrick ^a   Léonardon, Jacques ^a   Besnard, François ^a   Graham, David ^a   Depoortere, Henri ^a   Scatton, Bernard ^a  

^a SANOFI   (France)

Author keywords

eliprodil; ifenprodil; N methyl D aspartate receptor; voltage clamp; Xenopus oocytes

Indexed keywords

5,7 DICHLORO 1,2,3,4 TETRAHYDRO 4 (3 PHENYLUREIDO) 2 QUINOLINECARBOXYLIC ACID; 7 CHLOROKYNURENIC ACID; DEXTROMETHORPHAN; DIZOCILPINE; ELIPRODIL; IFENPRODIL; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VOLTAGE CLAMP; XENOPUS;

ANIMALS; BINDING SITES; ELECTRIC CONDUCTIVITY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; PATCH-CLAMP TECHNIQUES; PIPERIDINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; XENOPUS;

EID: 0342617537     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)13422-X     Document Type: Article

References (21)

1. Avenet, P., Léonardon, J., Besnard, F., Graham, D., Frost, J., Depoortere, H., Langer, S.Z. and Scatton, B., Antagonist properties of the stereoisomers of ifenprodil at NR1/NR2A and NR1/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes, Eur. J. Pharmacol., 296 (1996) 209-213.
2. 2. channels in rat cultured cortical neurons, Eur. J. Pharmacol., 257 (1994) 297-301.
3. 2. channels by the NMDA receptor antagonist eliprodil in acutely dissociated rat Purkinje cells, Eur. J. Pharmacol., 294 (1995) 91-100.
4. Bresink, I., Danysz, W., Parsons, C.G. and Mutschler, E., Different binding affinities of NMDA receptor channel blockers in various brain regions - indication of NMDA receptor heterogeneity, Neuropharmacology, 34 (1995) 533-540.
5. Buller, A.L., Larson, H.C., Schneider, B.E., Beaton, J.A., Morrisett, R.A. and Monaghan, D.T., The molecular basis of NMDA receptor subtypes native receptor diversity is predicted by subunit composition, J. Neurosci., 14 (1994) 5471-5484.
6. 2. channels in rat and mouse cultured hippocampal pyramidal neurones comparison with N-methyl-d-aspartate receptor antagonist actions, Br. J. Pharmacol., 113 (1994) 499-507.
7. Danysz, W., Parsons, C.G., Bresink, I. and Quack, G., Glutamate in CNS disorders, Drug News Perspect., 8 (1995) 261-277.
8. Gotti, B., Duverger, D., Bertin, J., Carter, C., Dupont, R., Frost, J., Gaudilliere, B., MacKenzie, E.T., Rousseau, J., Scatton, B. and Wick, A., Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents I. Evidence for efficacy in models of focal cerebral ischemia, J. Pharmacol. Exp. Ther., 247 (1988) 1211-1221.
9. Ishii, T., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H., Yokoi, M., Akazawa, C., Shigemoto, R., Mizuno, N., Masu, M. and Nakanishi, S., Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits, J. Biol. Chem., 268 (1993) 2836-2843.
10. Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Masaki, H., Kumanishi, T., Arakawa, M. and Mishina, M., Molecular diversity of the NMDA receptor channel, Nature, 358 (1992) 36-41.
11. Laurie, D.J. and Seeburg, P.H., Ligand affinities at recombinant N-methyl-d-aspartate receptors depend on subunit composition, Eur. J. Pharmacol., 268 (1994) 335-345.
12. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B. and Seeburg, P.H., Heteromeric NMDA receptors molecular and functional distinction of subtypes, Science, 256 (1992) 1217-1221.
13. Mori, H. and Mishina, M., Structure and function of the NMDA receptor channel, Neuropharmacology, 34 (1995) 1219-1237.
14. Netzer, R., Pfimlin, P. and Trube, G., Dextromethorphan blocks N-methyl-d-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons, Eur. J. Pharmacol., 238 (1993) 209-216.
15. Parsons, C.G., Gruner, R., Rozental, J., Millar, J. and Lodge, D., Patch-clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan), Neuropharmacology, 32 (1993) 1337-1350.
16. Parsons, C.G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S. and Danysz, W., Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo, Neuropharmacology, 34(1995) 1239-1258.
17. Scatton, B., Excitatory amino acid receptor antagonists a novel treatment for ischemic cerebrovascular diseases, Life Sci., 55 (1994) 2115-2124.
18. Scatton, B., Avenet, P., Benavides, J., Carter, C., Duverger, D., Oblin, A., Perrault, G., Sanger, D.J. and Schoemaker, H., Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists-ifenprodil and eliprodil. In M.G. Palfreyman, I.J. Reynolds and P. Skolnick (Eds), Direct and Allosteric Control of Glutamate Receptors, CRC Press, London, 1994, pp. 139-154.
19. Siesjö, B.K., Pathophysiology and treatment of focal cerebral ischemia. Part II: mechanisms of damage and treatment, J. Neurosurg., 77 (1992) 337-354.
20. Vender, J.R., Nair, S.N. and Lehmann, J.C., Pharmacotherapeutic potential for compounds acting at NMDA receptors: update 1995, Exp. Opin. Invest. Drugs, 4 (1995) 475-485.
21. Williams, K., Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors, Mol. Pharmacol., 44 (1993) 851-859.